Lassa fever pathophysiology: Difference between revisions
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
Line 25: | Line 25: | ||
*Lassa fever may potentially infect all organs, but the liver is commonly involved. | *Lassa fever may potentially infect all organs, but the liver is commonly involved. | ||
*Failure to | *Failure of the host to mount an adequate cellular [[immune response]] to control viral dissemination, along with disseminated replication in [[tissues]] and absence of neutralizing [[antibodies]], results in host death.<ref name="pmid20360949">{{cite journal| author=Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M et al.| title=T cell-dependence of Lassa fever pathogenesis. | journal=PLoS Pathog | year= 2010 | volume= 6 | issue= 3 | pages= e1000836 | pmid=20360949 | doi=10.1371/journal.ppat.1000836 | pmc=PMC2847900 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20360949 }} </ref> Prompt host immune response is critical for host survival, and fatal Lassa fever is often characterized by impaired or delayed [[cellular immunity]]<ref name="CDC">{{cite web | title = The Centers for Disease Control and Prevention | url =http://www.cdc.gov/vhf/lassa/transmission/index.html }}</ref>. | ||
==Gross Pathology== | ==Gross Pathology== |
Revision as of 15:15, 9 June 2015
Lassa fever Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lassa fever pathophysiology On the Web |
American Roentgen Ray Society Images of Lassa fever pathophysiology |
Risk calculators and risk factors for Lassa fever pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: Lassa hemorrhagic fever; LHF
Overview
Lassa fever may be transmitted from either infected animals (typically rodents) or humans following exposure to body fluids and excretions/secretions from the respiratory tract or GI tract. Following transmission, Lassa virus infects the endothelium and replicates intracellularly using an L-polymerase enzyme and nucleocapsid protein NP, which synthesize ribonucleoprotein (RNP) that produces mRNA and antigenomic RNA required for transcription. NP protein helps the virus evade the host immune system. Following transcription, vascular dysfunction ensues, resulting in the development of clinical manifestations of the disease. Although all organs may potentially be infected, the liver is a common target organ, and hepatitis/hepatic necrosis is typical following Lassa fever infection.
Transmission
Animal to Human
- Infection in humans typically occurs via exposure to animal (typically rodent) excrement through the respiratory or gastrointestinal tracts.
- Inhalation of tiny particles of infected aerosol is thought to be the most significant means of exposure, but transmission through direct exposure of infection to skin wounds or mucous membranes.
- Handling of dead infected animals has also been associated with the transmission of Lassa virus.
Human to Human
- Lassa virus may be transmitted following exposure to blood, tissue, secretions (including breast milk), or excretions of an infected individual.
- The virus cannot be transmitted without the exchange of body fluids.
Cellular Pathogenesis
- Following transmission, Lassa virus primarily infects the endothelial cells.
- Intracellular RNA synthesis is initiated within an L-polymerase enzyme, which utilizes viral RNA templates and nucleocapsid protein NP to synthesize viral ribonucleoprotein (RNP). Once synthesized, RNP is transmitted to the host cell cytoplasm, and transcription of mRNA and antigenomic RNA (agRNA).[1]
- Lassa fever evades the host immune system by production of NP protein, which has an exonuclease activity and causes the inhibition of host type I IFN signaling.[2]
- Endothelial dysfunction results in the release of pro-inflammatory cytokines and cell mediators[1], which in turn cause platelet dysfunction, hepatic necrosis, suppression of cardiac function, and development of Lassa fever-associated clinical manifestations, including facial edema, pleural and pericardial effusions, and hypovolemic shock.
- Lassa fever may potentially infect all organs, but the liver is commonly involved.
- Failure of the host to mount an adequate cellular immune response to control viral dissemination, along with disseminated replication in tissues and absence of neutralizing antibodies, results in host death.[3] Prompt host immune response is critical for host survival, and fatal Lassa fever is often characterized by impaired or delayed cellular immunity[4].
Gross Pathology
Lassa virus commonly involves the liver and results in hepatocellular necrosis and apoptosis. Other organs may be involved, and Lassa fever infection may manifest with the following:[5][6][7]
- Splenic necrosis
- Adrenocortical necrosis
- Mononuclear interstitial myocarditis
- Pulmonary alveolar edema with capillary congestion and mild interstitial pneumonitis
- Lymph nodal sinus histiocytosis
- Gastrointestinal mucosal petechiae
- Renal tubular injury
- Interstitial nephritis.
Microscopic Pathology
Typical features of Lassa fever-associated hepatitis include the following:
- Acidophilic necrosis
- Apoptotic changes
- Ballooning degeneration
- Pycnotic nuclei
- Microvascular changes
- Councilman bodies (intracellular inclusion bodies)
The images below display key features of microscopic pathology of Lassa virus.
-
This photomicrograph demonstrates hepatitis caused by the Lassa virus, using toluidine-blue azure II stain. Retrieved from the Public Health Image Library (PHIL) of the Centers for Disease Control and Prevention.Retrieved from the Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[8]
-
This transmission electron micrograph (TEM) demonstrates the cytoarchitectural changes of a liver tissue specimen extracted from a patient with Lassa fever. The presence of a typical Councilman body, pycnotic nuclei in an area of acidophilic necrosis, and microvacuolar fatty changes are noted.Retrieved from the Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[8]
-
Scanning electron micrograph (SEM) demonstrates the cytoarchitectural changes of a liver tissue specimen extracted from a patient with Lassa fever. A zone of acidophilic necrosis, and numbers of pycnotic nuclei are noted.Retrieved from the Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[8]
-
Sudan III-stained photomicrograph demonstrates the cytoarchitectural changes of a liver tissue specimen extracted from a patient with Lassa fever. Microvacuolar fatty necrosis is noted.Retrieved from the Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[8]
-
This photomicrograph demonstrates hepatitis caused by the Lassa virus, using toluidine-blue azure II stain, magnified 500X.Retrieved from the Public Health Image Library (PHIL), Centers for Disease Control and Prevention.[8]
References
- ↑ 1.0 1.1 Yun NE, Walker DH (2012). "Pathogenesis of Lassa fever". Viruses. 4 (10): 2031–48. doi:10.3390/v4102031. PMC 3497040. PMID 23202452.
- ↑ Martínez-Sobrido L, Zúñiga EI, Rosario D, García-Sastre A, de la Torre JC (2006). "Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus". J Virol. 80 (18): 9192–9. doi:10.1128/JVI.00555-06. PMC 1563941. PMID 16940530.
- ↑ Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M; et al. (2010). "T cell-dependence of Lassa fever pathogenesis". PLoS Pathog. 6 (3): e1000836. doi:10.1371/journal.ppat.1000836. PMC 2847900. PMID 20360949.
- ↑ "The Centers for Disease Control and Prevention".
- ↑ Frame JD, Baldwin JM, Gocke DJ, Troup JM (1970). "Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings". Am J Trop Med Hyg. 19 (4): 670–6. PMID 4246571.
- ↑ Walker DH, McCormick JB, Johnson KM, Webb PA, Komba-Kono G, Elliott LH; et al. (1982). "Pathologic and virologic study of fatal Lassa fever in man". Am J Pathol. 107 (3): 349–56. PMC 1916239. PMID 7081389.
- ↑ McCormick JB, Walker DH, King IJ, Webb PA, Elliott LH, Whitfield SG; et al. (1986). "Lassa virus hepatitis: a study of fatal Lassa fever in humans". Am J Trop Med Hyg. 35 (2): 401–7. PMID 3953952.
- ↑ 8.0 8.1 8.2 8.3 8.4 "Public Health Image Library (PHIL), Centers for Disease Control and Prevention".